2023-03-30T16:58:22+08:00 weekly 1.0 https://hu.prisysbiotech.com/ 2024-11-13T14:59:28+08:00 weekly 0.9 https://hu.prisysbiotech.com/inflammation-immunology-disorders 2024-11-13T14:59:19+08:00 weekly 0.9 https://hu.prisysbiotech.com/animal-welfare 2024-11-13T14:59:27+08:00 weekly 0.9 https://hu.prisysbiotech.com/metabolic-syndromes-research 2024-11-13T14:59:39+08:00 weekly 0.9 https://hu.prisysbiotech.com/respiratory-disease-research 2024-11-13T14:59:39+08:00 weekly 0.9 https://hu.prisysbiotech.com/ophthalmic-disease-research 2024-11-13T14:59:19+08:00 weekly 0.9 https://hu.prisysbiotech.com/translational-research-center 2024-11-13T14:59:28+08:00 weekly 0.9 https://hu.prisysbiotech.com/cns-disorders-behavior-analysis 2023-02-27T15:56:40+08:00 weekly 0.9 https://hu.prisysbiotech.com/co-develop 2024-11-13T14:59:31+08:00 weekly 0.9 https://hu.prisysbiotech.com/hematological-disease-research 2024-11-13T14:59:21+08:00 weekly 0.9 https://hu.prisysbiotech.com/download 2024-09-29T14:45:25+08:00 weekly 0.9 https://hu.prisysbiotech.com/nephrology 2024-09-29T14:23:03+08:00 weekly 0.9 https://hu.prisysbiotech.com/fibrosis 2024-11-13T14:59:19+08:00 weekly 0.9 https://hu.prisysbiotech.com/about-us 2024-11-13T14:59:20+08:00 weekly 0.9 https://hu.prisysbiotech.com/contact-us 2023-04-01T06:54:50+08:00 weekly 0.9 https://hu.prisysbiotech.com/newslist-1 2024-11-13T14:59:30+08:00 weekly 0.9 https://hu.prisysbiotech.com/products 2026-02-07T02:37:28+08:00 weekly 0.9 https://hu.prisysbiotech.com/blog/ 2023-04-01T06:36:56+08:00 weekly 1.0 https://hu.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T06:36:56+08:00 weekly 0.9 https://hu.prisysbiotech.com/biosafety-research/ 2023-04-01T06:36:56+08:00 weekly 0.9 https://hu.prisysbiotech.com/translation-research/ 2023-04-01T06:36:56+08:00 weekly 0.9 https://hu.prisysbiotech.com/pk-pd-adme/ 2023-04-01T06:36:59+08:00 weekly 0.9 https://hu.prisysbiotech.com/safety-evaluation/ 2024-04-09T04:00:26+08:00 weekly 0.9 https://hu.prisysbiotech.com/clearpoint/ 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2024-11-13T15:01:32+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2024-11-13T14:59:17+08:00 weekly 0.8 https://hu.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2024-11-13T14:59:21+08:00 weekly 0.8 https://hu.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/safety-evaluation/toxicology.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-11-13T14:59:22+08:00 weekly 0.8 https://hu.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/pk-pd-adme/adme.html 2024-11-13T15:00:57+08:00 weekly 0.8 https://hu.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2024-11-13T14:59:12+08:00 weekly 0.8 https://hu.prisysbiotech.com/translation-research/nhpresources.html 2024-11-13T14:59:21+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/translation-research/translational-studies.html 2024-11-13T14:59:17+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2024-11-13T14:59:26+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2024-11-13T14:59:30+08:00 weekly 0.8 https://hu.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2024-11-13T14:59:27+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2024-11-13T14:59:18+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2024-11-13T14:59:22+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2024-11-13T15:00:45+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2024-11-13T14:59:18+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2024-11-13T15:00:25+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2024-11-13T14:59:18+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2024-11-13T14:59:22+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2024-11-13T14:59:17+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2023-04-01T07:30:07+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-13T14:59:35+08:00 weekly 0.8 https://hu.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-13T14:59:31+08:00 weekly 0.8 https://hu.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-13T14:59:19+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-13T15:00:01+08:00 weekly 0.8 https://hu.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-28T23:43:15+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-09-28T23:43:15+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-09-28T23:43:16+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-09-28T23:43:19+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-09-28T23:43:22+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-28T23:43:24+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-11-13T14:59:33+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-12-07T15:29:55+08:00 weekly 0.8 https://hu.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2024-12-08T00:02:14+08:00 weekly 0.8 https://hu.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2025-04-01T18:09:26+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-04-01T18:09:29+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-07-20T10:56:58+08:00 weekly 0.8 https://hu.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-07-20T10:57:01+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-08-24T00:39:59+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-15T23:25:15+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-21T23:22:16+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-26T23:15:03+08:00 weekly 0.8 https://hu.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-10-05T13:23:52+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T22:44:28+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T21:20:11+08:00 weekly 0.8 https://hu.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2023-04-01T06:36:56+08:00 weekly 0.9 https://hu.prisysbiotech.com/newslist-714305-1 2023-04-01T06:55:09+08:00 weekly 0.9 https://hu.prisysbiotech.com/newslist-714313-1 2024-07-31T05:32:23+08:00 weekly 0.9 https://hu.prisysbiotech.com/newslist-819048-1 2023-04-01T06:55:06+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/meetprisys-sot2023-66131432.html 2023-04-01T06:55:07+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-sot2023-66131433.html 2023-04-01T06:55:07+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66131434.html 2023-04-01T06:55:07+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66131435.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66131735.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66131736.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66131983.html 2023-04-01T07:30:07+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/gene-therapy-nhp-model-66131984.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66132850.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66274573.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/gene-therapy-toxicology-66274575.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67545516.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/world-parkinsons-disease-day-67546333.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67546990.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67546993.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67548866.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67552157.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67559916.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67578163.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68120694.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68120695.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68120696.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68120697.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68322070.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69200760.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69200761.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69200762.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69200764.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69200765.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69200766.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309293.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309377.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309396.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309411.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69654751.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69655558.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/0-70979606.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70979607.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70979608.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70979609.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70979610.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70979624.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72323347.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72323349.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72323350.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72323352.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72328091.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72680949.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73024021.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73596620.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73596621.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74191160.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74684470.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74805129.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75172762.html 2024-11-13T14:59:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75172764.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76185421.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77068210.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77739162.html 2024-11-13T14:59:25+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77739185.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nhp-asthma-model-79200062.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79200063.html 2024-11-13T14:59:24+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79200066.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79200079.html 2024-11-13T14:59:24+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79200081.html 2024-11-13T14:59:26+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79447504.html 2024-11-13T14:59:28+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79447505.html 2024-11-13T14:59:25+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79447506.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79538905.html 2024-11-13T14:59:25+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/pk-strategies-of-pdc-79538906.html 2024-11-13T14:59:25+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79538908.html 2024-11-13T14:59:29+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79538910.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79538913.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79538914.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79538915.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79538916.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79538917.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79538918.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79538919.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79538920.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79538921.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79538922.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79538923.html 2024-11-13T14:59:31+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79538924.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79538925.html 2024-11-13T14:59:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79538926.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79538927.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79538928.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79538929.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79538930.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79538931.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79538932.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79538933.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79538934.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79538935.html 2024-11-13T14:59:26+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79538936.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79538937.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79538938.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79538939.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79538940.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79538941.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79538942.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79538943.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79538944.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79538945.html 2024-11-13T14:59:24+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79538946.html 2024-11-13T14:59:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/mrna-based-therapies-past-79538947.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79538948.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79538949.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79538950.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/mrna-based-therapies-present-79538951.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79538952.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79538954.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/significance-principles-and-requirements-of-79538955.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79538956.html 2024-08-07T08:44:38+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656496.html 2024-11-13T14:59:31+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/convection-enhanced-delivery-81192836.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/animal-models-of-human-diseases-81192837.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81192838.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/china-experimental-monkey-industry-81192839.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/human-disease-animal-models-81192840.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81192841.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81192842.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81192843.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81192844.html 2024-11-13T14:59:31+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81192845.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81192849.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/compartment-pk-model-81192850.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81192853.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82395269.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82726937.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82726938.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82726940.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82726941.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82726943.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82726947.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82726948.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82726950.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82726962.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83020041.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83025261.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83025713.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83978647.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83978648.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83978651.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83978652.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83978655.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83978660.html 2025-01-18T05:23:23+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83978672.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83978690.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83978726.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243115656389632.html 2025-02-26T21:54:12+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243115819525120.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295182415619072.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/animal-models-for-womens-health-17295182462690304.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295182473569280.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/membranous-nephropathy-model-17295182528996352.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295182531388416.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295182532355072.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295182562157568.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295182602167296.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295182650680320.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295182650975232.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295182667326464.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17295182796334080.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295182820828160.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295182856987648.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295182902420480.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295216019497984.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295216185598976.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17298401542087680.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374207471674368.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374207506080768.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374207553971200.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374207574533120.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374207629681664.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374207648949248.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374207682913280.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374207778546688.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374207829566464.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374207875621888.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374207927297024.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374248231527424.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17450470983164928.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17450471040328704.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17450471044981760.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17450471183639552.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17450471203185664.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/key-considerations-for-dosing-volume-17450471207543808.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17450471306421248.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17450471319004160.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17450471840736256.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17450506903069696.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17450507056669696.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17450507116946432.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17499409346421760.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17499409405715456.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nhp-copd-model-17499409425245184.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17499409465418752.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17499409529480192.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17499409531003904.html 2025-09-15T23:25:15+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/brain-targeted-drug-delivery-17531869264913408.html 2025-09-15T23:25:20+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17531869360563200.html 2025-09-15T23:25:19+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/the-importance-of-administration-volume-17531869388006400.html 2025-09-15T23:25:29+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17531869394854912.html 2025-09-15T23:25:34+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17531869395608576.html 2025-09-15T23:25:24+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17531869444432896.html 2025-09-15T23:25:24+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17531869700203520.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17540384955376640.html 2025-10-05T13:24:16+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17559590887973888.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17630708655236096.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17630708793992192.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17630708880516096.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17630708910023680.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17630708964713472.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17630708992648192.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17630709004182528.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/rfp-template-for-nhp-studies-17630709015979008.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17630709182637056.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/nhp-renal-biopsy-17630709322736640.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17630754113152000.html 2025-12-25T22:44:34+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674813111231488.html 2025-12-25T22:44:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674813131678720.html 2025-12-25T22:44:31+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674813222675456.html 2025-12-25T22:44:31+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674813269959680.html 2025-12-25T22:44:31+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674813300859904.html 2025-12-25T22:44:48+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674813342229504.html 2025-12-25T22:44:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674813495321600.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674827781645312.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674827860272128.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724289312662528.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724289336763392.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724289424434176.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724289430316032.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724289502372864.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724289618207744.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724289642308608.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724289733108736.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724289741726720.html 2026-04-02T01:54:42+08:00 weekly 0.8 https://hu.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724290037703680.html 2026-02-06T06:16:55+08:00 weekly 0.8 https://hu.prisysbiotech.com/blog/how-do-nhp-preclinical-studies-help-in-the-development-of-geriatric-drugs-2844578.html 2026-02-12T04:51:27+08:00 weekly 0.8 https://hu.prisysbiotech.com/blog/how-are-nhps-selected-for-a-study-2921463.html 2026-02-27T06:19:51+08:00 weekly 0.8 https://hu.prisysbiotech.com/blog/what-are-the-advantages-of-using-an-nhp-cro-3016066.html 2026-03-03T06:29:07+08:00 weekly 0.8 https://hu.prisysbiotech.com/blog/what-is-the-pharmacokinetic-profile-of-inhaled-drugs-3053038.html 2026-03-10T06:10:54+08:00 weekly 0.8 https://hu.prisysbiotech.com/blog/how-do-pd-drugs-influence-the-immune-cells-in-the-brain-in-pharmacology-3122306.html 2026-03-24T05:34:31+08:00 weekly 0.8 https://hu.prisysbiotech.com/blog/how-to-measure-the-infarct-volume-in-the-mcao-nhp-model-3321686.html